NO20060193L - Regulering av matriksmetallproteinasegenekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler - Google Patents

Regulering av matriksmetallproteinasegenekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler

Info

Publication number
NO20060193L
NO20060193L NO20060193A NO20060193A NO20060193L NO 20060193 L NO20060193 L NO 20060193L NO 20060193 A NO20060193 A NO 20060193A NO 20060193 A NO20060193 A NO 20060193A NO 20060193 L NO20060193 L NO 20060193L
Authority
NO
Norway
Prior art keywords
specific
cartilage
gene expression
regulation
electromagnetic signals
Prior art date
Application number
NO20060193A
Other languages
English (en)
Inventor
Carl T Brighton
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Publication of NO20060193L publication Critical patent/NO20060193L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61H—PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY
    • A61H39/00—Devices for locating or stimulating specific reflex points of the body for physical therapy, e.g. acupuncture
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/326—Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/40—Applying electric fields by inductive or capacitive coupling ; Applying radio-frequency signals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Rehabilitation Therapy (AREA)
  • Pain & Pain Management (AREA)
  • Radiology & Medical Imaging (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Magnetic Treatment Devices (AREA)

Abstract

Fremgangsmåter og enheter for regulering av matriks metalloproteinase i bruskceller via påføring av felt generert av spesifikke og selektive elektromagnetiske signaler ved behandling av sykt eller skadet leddbrusk. Ved genekspresjon er det ment oppregulering eller nedregulering av prosesser der spesifikke deler (gener) til det humane genomet (DNA) er transkribert til mRNA og således translatert til protein. Fremgangsmåter og enheter som tilveiebringer den målrettede behandlingen av skadet eller sykt bruskvev som inkluderer generering av spesifikke og selektive og elektromagnetiske signaler som genererer felt optimalisert ved reduksjon av matriks metalloproteinase genekspresjon og eksponerer bruskvev til felt generert av spesifikke og selektive signaler, slik at det kan regulere matriks metalloproteinase genekspresjon i slike bruskvev. De resulterende fremgangsmåtene og enhetene er nyttige for målrettet behandling av osteoartritt, reumatoid artritt, bruskskader, bruskdefekter og tumormetastaser.
NO20060193A 2003-06-13 2006-01-12 Regulering av matriksmetallproteinasegenekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler NO20060193L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/461,188 US7429471B2 (en) 2000-02-23 2003-06-13 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
PCT/US2004/019137 WO2004112708A2 (en) 2003-06-13 2004-06-14 Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals

Publications (1)

Publication Number Publication Date
NO20060193L true NO20060193L (no) 2006-03-06

Family

ID=33538972

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060193A NO20060193L (no) 2003-06-13 2006-01-12 Regulering av matriksmetallproteinasegenekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler

Country Status (14)

Country Link
US (1) US7429471B2 (no)
EP (1) EP1643953A4 (no)
JP (1) JP2007502693A (no)
KR (1) KR100856964B1 (no)
CN (1) CN1822807A (no)
AU (1) AU2004249202A1 (no)
BR (1) BRPI0411369A (no)
CA (1) CA2529374C (no)
CR (1) CR8145A (no)
EG (1) EG24170A (no)
IL (1) IL172508A0 (no)
MX (1) MXPA05013493A (no)
NO (1) NO20060193L (no)
WO (1) WO2004112708A2 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7429471B2 (en) 2000-02-23 2008-09-30 The Trustees Of The University Of Pennsylvania Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
US7022506B2 (en) * 2000-02-23 2006-04-04 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
US8313908B2 (en) 2000-02-23 2012-11-20 The Trustees Of The University Of Pennsylvania Regulation of stem cell gene production with specific and selective electric and electromagnetic fields
US7981611B2 (en) * 2000-02-23 2011-07-19 The Trustees Of The University Of Pennsylvania Regulation of fibroblastic growth factor-2 (FGF-2) gene expression in living cells with the application of specific and selective electric and electromagnetic fields
US7465566B2 (en) * 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of genes via application of specific and selective electrical and electromagnetic signals
US7465546B2 (en) * 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of transforming growth factor-beta (TGF-β) gene expression in living cells via the application of specific and selective electric and electromagnetic fields
US7374916B2 (en) 2000-02-23 2008-05-20 The Trustees Of The University Of Pennsylvania Regulation of aggrecan gene expression using specific and selective electrical and electromagnetic signals
US7215995B2 (en) * 2003-11-14 2007-05-08 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis and cartilage disease, defects, and injuries in the human hip
US9427598B2 (en) 2010-10-01 2016-08-30 Rio Grande Neurosciences, Inc. Method and apparatus for electromagnetic treatment of head, cerebral and neural injury in animals and humans
US9656096B2 (en) 2003-12-05 2017-05-23 Rio Grande Neurosciences, Inc. Method and apparatus for electromagnetic enhancement of biochemical signaling pathways for therapeutics and prophylaxis in plants, animals and humans
US9415233B2 (en) 2003-12-05 2016-08-16 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurological pain
US9433797B2 (en) 2003-12-05 2016-09-06 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurodegenerative conditions
US8961385B2 (en) 2003-12-05 2015-02-24 Ivivi Health Sciences, Llc Devices and method for treatment of degenerative joint diseases with electromagnetic fields
US9440089B2 (en) 2003-12-05 2016-09-13 Rio Grande Neurosciences, Inc. Apparatus and method for electromagnetic treatment of neurological injury or condition caused by a stroke
US10350428B2 (en) 2014-11-04 2019-07-16 Endonovo Therapetics, Inc. Method and apparatus for electromagnetic treatment of living systems
JP4801802B2 (ja) * 2004-01-12 2011-10-26 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 特定の選択的な電気信号および電磁信号によって生成される電場の印加を介して骨細胞における骨形成タンパク質（ｂｍｐ）遺伝子発現を上方制御するシステムおよび方法
KR20070024533A (ko) 2004-04-19 2007-03-02 아이비비 테크놀로지스, 아이엔씨. 전자기 치료 장치 및 방법
US7610100B2 (en) * 2005-12-30 2009-10-27 Boston Scientific Neuromodulation Corporation Methods and systems for treating osteoarthritis
US20090018613A1 (en) * 2006-08-02 2009-01-15 Genestim, Llc Regulation of vascular endothelial growth factor (vegf) gene expression in tissue via the application of electric and/or electromagnetic fields
US8343027B1 (en) 2012-01-30 2013-01-01 Ivivi Health Sciences, Llc Methods and devices for providing electromagnetic treatment in the presence of a metal-containing implant
EP2703001A1 (en) * 2012-08-26 2014-03-05 XAX Kft. Tumor vaccination
US9320913B2 (en) 2014-04-16 2016-04-26 Rio Grande Neurosciences, Inc. Two-part pulsed electromagnetic field applicator for application of therapeutic energy
WO2016129846A1 (ko) * 2015-02-12 2016-08-18 최규환 토양 미생물을 이용한 음식물 쓰레기 발효 장치및 축분 비료화 장치, 이에 적합한 바이오필드 발생 장치, 이에 적합한 미생물 전지 및 이에 적합한 미생물 콘덴서
US10806942B2 (en) 2016-11-10 2020-10-20 Qoravita LLC System and method for applying a low frequency magnetic field to biological tissues

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4506674A (en) 1981-11-10 1985-03-26 Trustees Of The University Of Pennsylvania Method of stimulating osteogenesis with distributed port cathode
US4430999A (en) 1981-11-10 1984-02-14 Trustees Of The University Of Pennsylvania Osteogenesis stimulating cathode assembly for use with an internal fixation device
US4442846A (en) 1981-11-10 1984-04-17 University Of Pennsylvania Distributed port bone-piercing cathode for electrically stimulated osteogenesis
US4509520A (en) 1982-02-22 1985-04-09 Biolectron, Inc. Electrical stimulating apparatus
US4549547A (en) 1982-07-27 1985-10-29 Trustees Of The University Of Pennsylvania Implantable bone growth stimulator
US4467809A (en) * 1982-09-17 1984-08-28 Biolectron, Inc. Method for non-invasive electrical stimulation of epiphyseal plate growth
US4487834A (en) 1982-09-17 1984-12-11 Biolectron, Inc. Electrical stimulation of articular chondrocytes
US4467808A (en) 1982-09-17 1984-08-28 Biolectron, Inc. Method for preventing and treating osteoporosis in a living body by using electrical stimulation non-invasively
US5269746A (en) 1982-12-20 1993-12-14 Jacobson Jerry I Therapeutic treatment of mammals for epilepsy and Parkinson's disease
US4535775A (en) 1983-02-10 1985-08-20 Biolectron, Inc. Method for treatment of non-union bone fractures by non-invasive electrical stimulation
IT1159024B (it) 1983-06-02 1987-02-25 Ruggero Cadossi Metodo e dispositivo per il trattamento di tessuti e cellule viventi mediante campi elettromagnetici pulsanti
US4600010A (en) * 1984-10-04 1986-07-15 Biolectron, Inc. Electric stimulator and test instrument therefor
US4998532A (en) 1986-05-23 1991-03-12 Lti Biomedical, Inc. Portable electro-therapy system
US5014699A (en) 1986-05-23 1991-05-14 Trustees Of The University Of Pennsylvania Electromagnetic method and apparatus for healing living tissue
US6120502A (en) 1988-06-13 2000-09-19 Michelson; Gary Karlin Apparatus and method for the delivery of electrical current for interbody spinal arthrodesis
CA2004192A1 (en) * 1988-11-30 1990-05-31 Jerry I. Jacobson Therapeutic treatment of mammals
US5038797A (en) 1990-02-20 1991-08-13 Romaine, Incorporated Electrical stimulation treatment device and method of use
US5273033A (en) 1991-09-19 1993-12-28 Murray Electronics Associates Limited Partnership Electrical stimulation for treatment of osteoarthritis
US5338286A (en) 1992-12-08 1994-08-16 Electro-Biology, Inc. Electromagnetic bioresponse by selective spectral suppression in pulsed field stimulation
US5374283A (en) 1993-12-01 1994-12-20 Flick; A. Bart Electrical therapeutic apparatus
US6356555B1 (en) * 1995-08-25 2002-03-12 Terayon Communications Systems, Inc. Apparatus and method for digital data transmission using orthogonal codes
US5743844A (en) 1996-11-01 1998-04-28 Amei Technologies, Inc. High efficiency pulsed electromagnetic field (PEMF) stimulation therapy method and system
US6132362A (en) 1996-11-01 2000-10-17 Amei Technologies, Inc. Pulsed electromagnetic field (PEMF) stimulation therapy system with bi-phasic coil
US6261221B1 (en) 1996-11-01 2001-07-17 Amei Technologies Inc. Flexible coil pulsed electromagnetic field (PEMF) stimulation therapy system
US5968527A (en) 1997-02-27 1999-10-19 Catholic University Of America, The Protection of living systems from the adverse effects of stress
US6083149A (en) 1997-10-22 2000-07-04 Emf Therapeutics, Inc. Magnetic field device and method for inhibiting angiogenesis and retarding growth rates of tumors in mammals
US6186940B1 (en) 1998-05-18 2001-02-13 Robert N. Kirschbaum Energized trace elements
US6292699B1 (en) 1999-01-29 2001-09-18 Electro-Biology, Inc. Direct current stimulation of spinal interbody fixation device
CA2335966A1 (en) 1999-04-29 2000-11-09 North Shore Long Island Jewish Research Corporation Method for inducing growth and enhancing survival of nervous tissue
DE19933719A1 (de) 1999-07-19 2001-01-25 Medigene Ag Strukturprotein in Adeno-assoziiertem Virus mit veränderten chromatographischen Eigenschaften, seine Herstellung und Verwendung
US7465566B2 (en) 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of genes via application of specific and selective electrical and electromagnetic signals
US7429471B2 (en) 2000-02-23 2008-09-30 The Trustees Of The University Of Pennsylvania Regulation of matrix metalloproteinase gene expression using specific and selective electrical and electromagnetic signals
US7022506B2 (en) 2000-02-23 2006-04-04 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis, cartilage disease, defects and injuries in the human knee
US7465546B2 (en) 2000-02-23 2008-12-16 The Trustees Of The University Of Pennsylvania Regulation of transforming growth factor-beta (TGF-β) gene expression in living cells via the application of specific and selective electric and electromagnetic fields
US7130692B2 (en) 2000-02-23 2006-10-31 The Trustees Of The University Of Pennsylvania Portable electrotherapy device for treating osteoarthritis and other diseases, defects and injuries of the knee joint
US6919205B2 (en) 2000-02-23 2005-07-19 The Trustees Of The University Of Pennsylvania Regulation of type II collagen gene expression using specific and selective electrical and electromagnetic signals
US6485963B1 (en) 2000-06-02 2002-11-26 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Growth stimulation of biological cells and tissue by electromagnetic fields and uses thereof
AU2002227147A1 (en) 2000-11-02 2002-05-15 Keith L March Method and system for modulation of oscillating signals to enhance biologic effects
US6485113B2 (en) 2001-03-08 2002-11-26 Delphi Technologies, Inc. Haptic braking method and system
WO2003004092A2 (en) 2001-07-03 2003-01-16 The Trustees Of The University Of Pennsylvania Device and method for electrically inducing osteogenesis in the spine
AU2002329223B2 (en) 2001-12-21 2007-11-22 The Trustees Of The University Of Pennsylvania Device for treating osteoporosis, hip and spine fractures and fusions with electric fields
US6955642B1 (en) 2002-11-26 2005-10-18 Ebi, Lp Pulsed electromagnetic field stimulation method and apparatus with improved dosing
US7215995B2 (en) 2003-11-14 2007-05-08 The Trustees Of The University Of Pennsylvania Method and device for treating osteoarthritis and cartilage disease, defects, and injuries in the human hip
JP4801802B2 (ja) 2004-01-12 2011-10-26 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルバニア 特定の選択的な電気信号および電磁信号によって生成される電場の印加を介して骨細胞における骨形成タンパク質（ｂｍｐ）遺伝子発現を上方制御するシステムおよび方法

Also Published As

Publication number Publication date
KR20060024797A (ko) 2006-03-17
US7429471B2 (en) 2008-09-30
CN1822807A (zh) 2006-08-23
KR100856964B1 (ko) 2008-09-04
EG24170A (en) 2008-09-14
WO2004112708A2 (en) 2004-12-29
EP1643953A4 (en) 2008-11-05
EP1643953A2 (en) 2006-04-12
JP2007502693A (ja) 2007-02-15
BRPI0411369A (pt) 2006-08-01
MXPA05013493A (es) 2007-03-15
AU2004249202A1 (en) 2004-12-29
IL172508A0 (en) 2006-04-10
CA2529374A1 (en) 2004-12-29
WO2004112708A3 (en) 2005-02-24
CA2529374C (en) 2010-01-26
US20040138709A1 (en) 2004-07-15
CR8145A (es) 2006-07-14

Similar Documents

Publication Publication Date Title
NO20060193L (no) Regulering av matriksmetallproteinasegenekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler
NO20052254L (no) Regulering av type II collagen-genekspresjon ved anvendelse av spesifikke og selektive elektriske og elektromagnetiske signaler
NO20051947L (no) Regulering av aggrecan genekspresjonen ved bruk av spesifikk og selektiv elektriske og elektromagnetiske signaler
NO20063444L (no) System og metode for oppregulering av benmorfogenetisk proteingenekspresjon i benceller ved anvendelse av felt generert av spesifikke og selektive elektriske og elektromagnetiske signaler
Mellor et al. Dynamic regulation of auxin oxidase and conjugating enzymes AtDAO1 and GH3 modulates auxin homeostasis
Ke et al. Fourth generation of Next‐Generation sequencing technologies: promise and consequences
Besaratinia et al. Riboflavin activated by ultraviolet A1 irradiation induces oxidative DNA damage-mediated mutations inhibited by vitamin C
MX2018008440A (es) Vectores de terapia genica y citosina deaminasas.
BRPI0606120A2 (pt) sistema para tratamento de tecidos biológicos com descarga gasosa de plasma
Xing et al. Investigating epithelial-to-mesenchymal transition with integrated computational and experimental approaches
Su et al. Natural antisense transcripts regulate gene expression in an epigenetic manner
Tuli et al. p38 MAP kinase regulation of AP‐2 binding in TGF‐β1‐stimulated chondrogenesis of human trabecular bone‐derived cells
Facchin et al. Tissue regeneration without stem cell transplantation: Self‐healing potential from ancestral chemistry and physical energies
Li et al. DNA N6-methyladenine modification in eukaryotic genome
Kosmoski et al. DNA repair of a single UV photoproduct in a designed nucleosome
Liu et al. Small-molecule-mediated split-aptamer assembly for inducible CRISPR-dCas9 transcription activation
Shin et al. MMP‐9‐dependent proteolysis of the histone H3 N‐terminal tail: a critical epigenetic step in driving oncogenic transcription and colon tumorigenesis
ATE287722T1 (de) Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1
ATE499440T1 (de) Gen-targeting mit replizierenden dna-molekülen
Walters et al. Identification and characterisation of temporal abundance of microRNAs in synovial fluid from an experimental equine model of osteoarthritis
MX2010008765A (es) Regulacion de expresion de genes de factor de crecimiento de fibroblastos-2 (fgf-2) en celulas vivas con la aplicacion de campos electricos y electromagnetivos especificos y selectivos.
WO2008073154A3 (en) Methods and compositions for treating disease
Yoshimura et al. Identification of c‐Jun N‐terminal kinase as a therapeutic target for abdominal aortic aneurysm
Pinton et al. Specific low-frequency electromagnetic fields induce expression of active KDM6B associated with functional changes in U937 cells
Semenov et al. Splicing by Exon Exclusion Impaired by Artificial Box C/D RNA Targeted to Branch‐Point Adenosine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application